Firmabeskrivelse

Representative Investments by Florian Schönharting

Role: Co-Founder
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and autoimmune diseases, based on proprietary next generation antibody technologies.
Ticker: GEN.CO - Market cap: